新型/新兴精神活性物质及其相关精神病理后果 - 勘误 - Suppr | 超能文献

相似文献

1

New/emerging psychoactive substances and associated psychopathological consequences - Corrigendum.新型/新兴精神活性物质及其相关精神病理后果 - 勘误

Psychol Med. 2021 Jan;51(1):43. doi: 10.1017/S003329171900254X. Epub 2019 Sep 12.

2

The rise of new psychoactive substances and psychiatric implications: A wide-ranging, multifaceted challenge that needs far-reaching common legislative strategies.新精神活性物质的兴起及其对精神健康的影响：广泛而复杂的挑战，需要采取广泛而深远的共同立法策略。

Hum Psychopharmacol. 2020 May;35(3):e2727. doi: 10.1002/hup.2727. Epub 2020 Mar 7.

3

[Clinical symptoms and personality traits in patients using psychostimulant drugs and other psychoactive substances].

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(1. Vyp. 2):10-15. doi: 10.17116/jnevro20181181210-15.

4

Monitoring the Internet for emerging psychoactive substances available to Australia.监测澳大利亚可获得的新兴精神活性物质的互联网情况。

Drug Alcohol Rev. 2013 Sep;32(5):541-4. doi: 10.1111/dar.12049. Epub 2013 May 6.

5

[New psychoactive substances abuse among patients with access to methadone maintenance treatment in Jiangsu province: a case-control study].[江苏省接受美沙酮维持治疗患者中新精神活性物质滥用情况：一项病例对照研究]

Zhonghua Liu Xing Bing Xue Za Zhi. 2018 May 10;39(5):625-630. doi: 10.3760/cma.j.issn.0254-6450.2018.05.016.

6

Prescription Drug Misuse in "Clubbers" and Disco Goers in Ibiza.伊维萨岛“夜店族”和迪斯科爱好者中的处方药滥用情况。

Front Psychiatry. 2020 Dec 15;11:592594. doi: 10.3389/fpsyt.2020.592594. eCollection 2020.

7

Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.新精神活性物质能否得到有效管制？对英国《精神药品法案》的评估。

Addiction. 2017 Jan;112(1):25-31. doi: 10.1111/add.13439. Epub 2016 May 24.

8

What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.在新西兰新型精神活性物质（NPS，“合法兴奋剂”）的合法市场中，哪些产品被视为具有精神活性？对执法和处罚的影响。

Drug Test Anal. 2016 Aug;8(8):768-78. doi: 10.1002/dta.1943. Epub 2016 Feb 9.

9

The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.日本加强监管对新型精神活性物质相关障碍患者的影响。

Neuropsychopharmacol Rep. 2018 Dec;38(4):189-196. doi: 10.1002/npr2.12035. Epub 2018 Oct 19.

10

New psychoactive substances: Are there any good options for regulating new psychoactive substances?新型精神活性物质：对于管控新型精神活性物质，是否存在任何可行的办法？

Int J Drug Policy. 2017 Feb;40:117-122. doi: 10.1016/j.drugpo.2016.10.020. Epub 2016 Nov 23.

引用本文的文献

1

Dopamine transporter blockade during adolescence increases adult dopamine function, impulsivity, and aggression.青少年时期多巴胺转运蛋白阻断会增加成年后的多巴胺功能、冲动性和攻击性。

Mol Psychiatry. 2023 Aug;28(8):3512-3523. doi: 10.1038/s41380-023-02194-w. Epub 2023 Aug 2.

2

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population.意大利的非处方药认知和使用情况：基于普通人群的探索性调查研究。

Curr Neuropharmacol. 2023;21(1):133-141. doi: 10.2174/1570159X20666220714104231.

3

Self-reported Subjective Effects of Analytically Confirmed New Psychoactive Substances Consumed by e-Psychonauts: Protocol for a Longitudinal Study Using a New Internet-Based Methodology.